Zoryve (roflumilast)

$679.00

We can help with your prescription. Read the “Prescription Guide”.

You can access this medicine even if it’s not approved in your country. Learn how.

Zoryve (roflumilast) cream 0.3% is a topical PDE4 inhibitor indicated for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. Zoryve was approved by the FDA in July 2022.

SKU: N/A Category: